These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 23682134

  • 1. Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis.
    Suominen MI, Rissanen JP, Käkönen R, Fagerlund KM, Alhoniemi E, Mumberg D, Ziegelbauer K, Halleen JM, Käkönen SM, Scholz A.
    J Natl Cancer Inst; 2013 Jun 19; 105(12):908-16. PubMed ID: 23682134
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.
    Szafran AA, Folks K, Warram J, Chanda D, Wang D, Zinn KR.
    Cancer Biol Ther; 2009 Jun 19; 8(12):1109-16. PubMed ID: 19652526
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone.
    Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE, Holen I.
    Mol Cancer Ther; 2009 Oct 19; 8(10):2821-32. PubMed ID: 19789217
    [Abstract] [Full Text] [Related]

  • 7. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.
    Daubiné F, Le Gall C, Gasser J, Green J, Clézardin P.
    J Natl Cancer Inst; 2007 Feb 21; 99(4):322-30. PubMed ID: 17312309
    [Abstract] [Full Text] [Related]

  • 8. Management of bone metastases in prostate cancer: a review.
    Bienz M, Saad F.
    Curr Opin Support Palliat Care; 2015 Sep 21; 9(3):261-7. PubMed ID: 26262831
    [Abstract] [Full Text] [Related]

  • 9. Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model.
    Suominen MI, Mäki-Jouppila J, Huhtinen A, Sjöholm B, Rissanen JP, Luostarinen A, Fagerlund KM, Alhoniemi E, Siemeister G, Mumberg D, Käkönen SM, Scholz A.
    Int J Mol Sci; 2021 May 25; 22(11):. PubMed ID: 34070363
    [Abstract] [Full Text] [Related]

  • 10. Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.
    Ottewell PD, Mönkkönen H, Jones M, Lefley DV, Coleman RE, Holen I.
    J Natl Cancer Inst; 2008 Aug 20; 100(16):1167-78. PubMed ID: 18695136
    [Abstract] [Full Text] [Related]

  • 11. Radium-223 dichloride: a review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastases.
    Shirley M, McCormack PL.
    Drugs; 2014 Apr 20; 74(5):579-86. PubMed ID: 24610703
    [Abstract] [Full Text] [Related]

  • 12. Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation.
    Yang C, Davis JL, Zeng R, Vora P, Su X, Collins LI, Vangveravong S, Mach RH, Piwnica-Worms D, Weilbaecher KN, Faccio R, Novack DV.
    Cancer Discov; 2013 Feb 20; 3(2):212-23. PubMed ID: 23269702
    [Abstract] [Full Text] [Related]

  • 13. Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications for breast cancer bone metastasis.
    Haider MT, Holen I, Dear TN, Hunter K, Brown HK.
    Bone; 2014 Sep 20; 66(100):240-50. PubMed ID: 24971713
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options.
    Gartrell BA, Coleman R, Efstathiou E, Fizazi K, Logothetis CJ, Smith MR, Sonpavde G, Sartor O, Saad F.
    Eur Urol; 2015 Nov 20; 68(5):850-8. PubMed ID: 26153564
    [Abstract] [Full Text] [Related]

  • 18. The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model.
    Luo KW, Ko CH, Yue GG, Gao S, Lee JK, Li G, Fung KP, Leung PC, Evdokiou A, Lau CB.
    J Cancer Res Clin Oncol; 2015 Jun 20; 141(6):1025-36. PubMed ID: 25431338
    [Abstract] [Full Text] [Related]

  • 19. Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone.
    Takalkar A, Adams S, Subbiah V.
    Exp Hematol Oncol; 2014 Jun 20; 3():23. PubMed ID: 25243101
    [Abstract] [Full Text] [Related]

  • 20. Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models.
    Suominen MI, Fagerlund KM, Rissanen JP, Konkol YM, Morko JP, Peng Z, Alhoniemi EJ, Laine SK, Corey E, Mumberg D, Ziegelbauer K, Käkönen SM, Halleen JM, Vessella RL, Scholz A.
    Clin Cancer Res; 2017 Aug 01; 23(15):4335-4346. PubMed ID: 28364014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.